50 results on '"Mayerle, Julia"'
Search Results
2. Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
3. Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
4. Entzündliche Lebererkrankungen
5. Electronic data capture in resource-limited settings using the lightweight clinical data acquisition and recording system
6. Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
7. Pankreaszysten – Indikationen, Zeitpunkt und Rationale für eine Surveillance
8. Pankreaskarzinom – Screening oder Surveillance?
9. Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study
10. Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implications
11. Akute Pankreatitis - Diagnose und Management
12. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
13. Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
14. How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores
15. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
16. Pankreaszysten – Indikationen, Zeitpunkt und Rationale für eine Surveillance
17. Pankreaszysten – Indikationen, Zeitpunkt und Rationale für eine Surveillance
18. Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
19. Genetic Testing in Acute and Chronic Pancreatitis
20. CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver
21. Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
22. In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response
23. Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review
24. Konservative oder chirurgische Therapie der chronischen Pankreatitis?
25. Lipaseerhöhung
26. Prognoseverbesserung durch Screening- und Surveillance-Strategien für Leber- und Pankreaserkrankungen
27. Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
28. Carrying asymptomatic gallstones is not associated with changes in intestinal microbiota composition and diversity but cholecystectomy with significant dysbiosis
29. X-change symposium: status and future of modern radiation oncology—from technology to biology
30. Early trypsin activation develops independently of autophagy in caerulein-induced pancreatitis in mice
31. Pankreaskarzinom und Diabetes: Mal Folge, mal Ursache: Diabetologie
32. Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox
33. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model
34. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells
35. Vaskuläre Erkrankungen in Gastrointestinaltrakt und Leber
36. Pancreatic cancer: why the cell of origin matters
37. Development of amoebic liver abscess in early pregnancy years after initial amoebic exposure: a case report
38. SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine
39. Absence of the neutrophil serine protease cathepsin G decreases neutrophil granulocyte infiltration but does not change the severity of acute pancreatitis
40. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
41. Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
42. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
43. Webinar zur europäischen Leitlinie „Chronische Pankreatitis“: Webinar on the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
44. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
45. The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
46. Anatomic variants of the pancreatic duct and their clinical relevance: an MR-guided study in the general population
47. Drug-Induced Pancreatitis
48. Chronische Pankreatitis als Risikofaktor für ein Pankreaskarzinom – diagnostische Herausforderungen
49. EUS-guided Trucut needle biopsies as first-line diagnostic method for patients with intestinal or extraintestinal mass lesions
50. Is it necessary to distinguish between alcoholic and nonalcoholic chronic pancreatitis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.